Methylprednisolone and Meprobamate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylprednisolone (methylprednisolone) and Meprobamate (meprobamate). Common drug interactions include rheumatoid arthritis among females and hyperglycaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Methylprednisolone and Meprobamate. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.

What is Meprobamate?

Meprobamate has active ingredients of meprobamate. It is often used in stress and anxiety. eHealthMe is studying from 2,268 Meprobamate users. Check the latest studies of Meprobamate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 15, 2026

42 people who take Methylprednisolone and Meprobamate together, and have interactions are studied.

Methylprednisolone and Meprobamate drug interactions.

What are the common drug interactions of Methylprednisolone and Meprobamate, by gender? *:

female:

  1. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  2. Dyspnoea (difficult or laboured respiration)
  3. Drug ineffective
  4. Injection site reaction
  5. Mobility decreased (ability to move is reduced)
  6. Pain
  7. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
  8. Gait disturbance
  9. Hand deformity
  10. Deformity (disfigurement)

male:

  1. Hyperglycaemia (high blood sugar)
  2. Hypotension (abnormally low blood pressure)
  3. Arterial thrombosis (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system)
  4. Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
  5. Coma (state of unconsciousness lasting more than six hours)
  6. Pulse absent
  7. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Pyrexia (fever)
  10. Angioneurotic oedema (swelling that occurs just beneath the surface of the skin or mucous membranes)

What are the common drug interactions of Methylprednisolone and Meprobamate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Pleural effusion (water on the lungs)

60+:

  1. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  2. Dyspnoea (difficult or laboured respiration)
  3. Hyperglycaemia (high blood sugar)
  4. Hypotension (abnormally low blood pressure)
  5. Pruritus (severe itching of the skin)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Fatigue (feeling of tiredness)
  8. Pain in limb
  9. Rigors (an episode of shaking or exaggerated shivering)
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 27 people, 64.29%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone and Meprobamate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methylprednisolone and Meprobamate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylprednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Meprobamate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methylprednisolone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meprobamate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone and meprobamate (the active ingredients of Methylprednisolone and Meprobamate, respectively), and Methylprednisolone and Meprobamate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: